Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians

Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians

BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.

Saved in:

Bibliographic Details
Main Authors:	Curtis L Cooper, Robert J Bailey, Vince G Bain, Frank Anderson, Eric M Yoshida, Mel Krajden, Paul Marotta, for the Canadian Pegasys Study Group
Format:	Article
Language:	English
Published:	Wiley 2008-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2008/320150
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy
by: Eric M Yoshida, et al.
Published: (2009-01-01)

Efficacy and Safety of Low-Dose Peginterferon Alpha-2a Plus Ribavirin on Chronic Hepatitis C
by: Zehui Yan, et al.
Published: (2012-01-01)

Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)
by: Robert P Myers, et al.
Published: (2011-01-01)

Message from the President of the Canadian Association for the Study of the Liver
by: Vince Bain
Published: (2003-01-01)

Helicobacter Pylori Infection in Canadian and Related Arctic Aboriginal Populations
by: Karen J Goodman, et al.
Published: (2008-01-01)

Pegylated-Interferon Alpha 2b and Ribavirin for Recurrent Hepatitis C after Liver Transplantation: From a Canadian Experience to Recommendations for Therapy
by: Mohamed Babatin, et al.
Published: (2005-01-01)

Chronic Lung Disease in Canadian Aboriginal Children Is Not Caused by Abnormal Cilia
by: Bruce K Rubin, et al.
Published: (1997-01-01)

Treatment of chronic hepatitis C by cepeginterferon alpha-2b in combination to ribavirin
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy
by: Curtis Cooper, et al.
Published: (2014-01-01)

Ischemic Colitis During Pegylated Interferon-Alpha and Ribavirin Therapy for Chronic Hepatitis C
by: Yvette Leung, et al.
Published: (2006-01-01)

A Randomized Controlled Trial Comparing Sequential with Triple Therapy for Helicobacter pylori in an Aboriginal Community in the Canadian North
by: Amy L Morse, et al.
Published: (2013-01-01)

Marked Disparity in the Epidemiology of Tuberculosis among Aboriginal Peoples on the Canadian Prairies: the Challenges and Opportunities
by: Richard Long, et al.
Published: (2013-01-01)

Aboriginal cosmotechnics
by: Simon Sadler
Published: (2025-02-01)

Canadian Helicobacter pylori Consensus Conference Update: Infections in Adults
by: RH Hunt, et al.
Published: (1999-01-01)

High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C
by: David N Moskovitz, et al.
Published: (2003-01-01)

Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C
by: Louis WC Liu, et al.
Published: (2003-01-01)

Comparison of Late HIV Diagnosis as a Marker of Care for Aboriginal Versus Non-Aboriginal People Living with HIV in Ontario
by: Denise Jaworsky, et al.
Published: (2012-01-01)

Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepatitis C Virus
by: Cecilia T Costiniuk, et al.
Published: (2008-01-01)

Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
by: Hirokazu Suii, et al.
Published: (2017-01-01)

Barriers Preventing Liver Transplantation in Canadians with HIV Infection – Perceptions of HIV Specialists
by: Curtis L Cooper, et al.
Published: (2007-01-01)

The Management of Chronic Viral Hepatitis: A Canadian Consensus Conference 2004
by: Morris Sherman, et al.
Published: (2004-01-01)

Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma: The Canadian Multicentre Experience
by: Carmine G Nudo, et al.
Published: (2008-01-01)

Practical Approach to Issues in Virology
by: Mel Krajden
Published: (1996-01-01)

Canadian Consensus Conference on the Management of Viral Hepatitis
by: Association for Study of the Liver (CASL) Consensus Conference Rapporteur Group
Published: (2000-01-01)

Antimicrobial Regimens Prescribed by Canadian Physicians for Chemotherapy-Induced Febrile Neutropenic Episodes
by: Michel Laverdière, et al.
Published: (1999-01-01)

Hepatology and The Canadian Gastroenterologist: Interest, Attitudes and Patterns of Practise: Results of a National Survey from the Canadian Association of Gastroenterology
by: Vincent G Bain, et al.
Published: (2003-01-01)

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian Guidelines for Management and Treatment of HIV/Hepatitis C Coinfection in Adults
by: Mark Hull, et al.
Published: (2013-01-01)

Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter Pylori Infection in Children and Adolescents
by: P Sherman, et al.
Published: (1999-01-01)

Tuberculosis among Aboriginal and Nonaboriginal Persons in British Columbia
by: L Wang, et al.
Published: (2000-01-01)

Effect of Ribavirin on Hepatitis A Virus Replication In Vitro
by: Rabindra K Chaudhary, et al.
Published: (1992-01-01)

Summary of Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Disease Society and the Canadian Thoracic Society
by: Lionel A Mandell, et al.
Published: (2000-01-01)

Summary of Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
by: Lionel A Mandell, et al.
Published: (2000-01-01)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
by: Amit Chopra, et al.
Published: (2015-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease
by: Daniel C Sadowski, et al.
Published: (2009-01-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
by: Kaimin Song, et al.
Published: (2025-02-01)

Evaluating the role of selection in the evolution of mitochondrial genomes of aboriginal peoples of Siberia
by: B. A. Malyarchuk, et al.
Published: (2023-06-01)

Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin
by: Morris Sherman, et al.
Published: (2006-01-01)

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007)
by: George G Zhanel, et al.
Published: (2009-01-01)

The Canadian Multicentre MAC Treatment Study
by: Stephen D Shafran, et al.
Published: (1994-01-01)

Prevalence of and Risk Factors for Asthma in Off-Reserve Aboriginal Children and Adults in Canada
by: Hsiu-Ju Chang, et al.
Published: (2012-01-01)